Biotech and Pharma Stocks

Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.

BIOTECH & PHARMA

Race Oncology begins preparing for clinical breast cancer trials using bisantrene

Incannex Healthcare reveals positive in vivo results, will call Pre-IND meeting with FDA

Osteopore signs deal to distribute medical implant products through German and Austrian markets

Incannex Healthcare enters trading halt ahead of study results and FDA strategy

Investors throw support behind Alterity Therapeutics as it advances lead drug for Parkinsonian diseases

Alterity Therapeutics collars US patent for next generation compounds

Medical cannabis expert boosts Lifespot Health leadership ahead of vape pen trials

Alcidion Group secures $9.5m deal to supply smart platform to UK’s largest hospital trust

Incannex lead drug candidate exhibits stronger anti-inflammatory action than CBD in preclinical studies

Osteopore adds former ResMed executive Carl Runde to its board

THC Global reveals major strategic changes as part of broader shift into healthcare and pharmaceuticals

Pharmaxis secures US FDA approval for Bronchitol, sales to bankroll development of myelofibrosis drug candidate

Osteopore inks Australia and NZ distribution deal for bone healing scaffolds

Osteopore shrugs off COVID-19 to report 40% revenue growth

PharmAust posts strong September quarter led by advances in development of lead drug monepantel

Patrys granted Australian patent for Deoxymab platform with nanoparticles to deliver anti-cancer drugs

Incannex achieves record medicinal cannabis oil sales as pure play pharmaceutical company

Hydrix welcomes first AngelMed Guardian device implant in the US

Olivia Newton-John Cancer Research Institute evaluates PharmAust’s anti-cancer drug

Osprey Medical wins prestigious supplier award, secures more distribution deals for medical imaging technology

Incannex receives ethics approval for novel cannabinoid in phase 2b obstructive sleep apnoea trial